We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+23.34%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.06B
AUM Growth
+$217M
Cap. Flow
+$46.1M
Cap. Flow %
4.35%
Top 10 Hldgs %
19.28%
Holding
1,042
New
162
Increased
350
Reduced
349
Closed
87

Top Buys

Rank Stock Value
1
ESGV icon
Vanguard ESG US Stock ETF
ESGV
+$6.69M
2
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$5.29M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.28M
4
PTNQ icon
Pacer Trendpilot 100 ETF
PTNQ
+$3.37M
5
AIVC
Amplify Bloomberg AI Equal Weight ETF
AIVC
+$2.96M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$4.65M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$3M
3
UUP icon
Invesco DB US Dollar Index Bullish Fund
UUP
+$2.18M
4
PTLC icon
Pacer Trendpilot US Large Cap ETF
PTLC
+$1.36M
5
RTN
Raytheon Company
RTN
+$1.08M

Sector Composition

Rank Sector Weight
1 Technology 17.42%
2 Healthcare 10.07%
3 Consumer Discretionary 9.06%
4 Financials 7.61%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWN
876
DELISTED
Southwestern Energy Company
SWN
$64K 0.01%
25,000
-600
-2% -$1.71K
LJPC
877
DELISTED
La Jolla Pharmaceutical Company
LJPC
$64K 0.01%
+15,000
New +$91.3K
CIK
878
Credit Suisse Asset Management Income Fund
CIK
$134M
$63K 0.01%
23,116
-4,500
-16% -$11.6K
GALT icon
879
Galectin Therapeutics
GALT
$219M
$63K 0.01%
20,498
– –
XTNT icon
880
Xtant Medical Holdings
XTNT
$57.5M
$62K 0.01%
+69,259
New +$63.5K
FAX
881
abrdn Asia-Pacific Income Fund
FAX
$598M
$59K 0.01%
2,584
-34
-1% -$730
RKTO
882
Rocket One Inc
RKTO
$18M
$59K 0.01%
+914
New +$71.5K
AMPE
883
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$59K 0.01%
307
-129
-30% -$21.5K
NSPR icon
884
InspireMD
NSPR
$31.4M
$56K 0.01%
8,034
+5,456
+212% +$55.4K
ENTX icon
885
Entera Bio
ENTX
$175M
$55K 0.01%
+30,008
New +$61.2K
AVEO
886
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$55K 0.01%
+10,700
New +$67.5K
ASX icon
887
ASE Group
ASX
$77.8B
$54K 0.01%
11,992
-4,636
-28% -$19.8K
ATAXZ
888
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$53K 0.01%
12,835
+2,095
+20% +$8.65K
CLRB icon
889
Cellectar Biosciences
CLRB
$19.4M
$52K ﹤0.01%
+134
New +$56.3K
PHAS
890
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$52K ﹤0.01%
+11,400
New +$50.5K
TCON
891
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$50K ﹤0.01%
+1,285
New +$50.9K
DBRG icon
892
DigitalBridge
DBRG
$2.94B
$49K ﹤0.01%
5,071
-1,675
-25% -$14.5K
CYTO
893
DELISTED
Altamira Therapeutics Ltd
CYTO
$49K ﹤0.01%
+131
New +$49.2K
NSL
894
DELISTED
NUVEEN SENIOR INCM FD
NSL
$49K ﹤0.01%
10,395
– –
TENX icon
895
Tenax Therapeutics
TENX
$405M
$47K ﹤0.01%
+33
New +$48.5K
IFRX icon
896
InflaRx
IFRX
$250M
$46K ﹤0.01%
+10,000
New +$64.9K
VTVT icon
897
vTv Therapeutics
VTVT
$120M
$46K ﹤0.01%
515
+150
+41% +$14.8K
CLMT icon
898
Calumet Specialty Products
CLMT
$3.52B
$45K ﹤0.01%
19,837
-319
-2% -$682
XYLO
899
DELISTED
Xylo Technologies
XYLO
$45K ﹤0.01%
+650
New +$56.2K
IRD
900
Opus Genetics
IRD
$267M
$45K ﹤0.01%
+4,000
New +$36.8K
34 35
36
37 38

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q2 2020 Portfolio in Review

As of Q2 2020, Wedbush Securities held 1,042 positions worth $1.06B, up 26% from $840M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Wedbush Securities deployed $46.1M of net new capital in Q2 2020, opening 162 new positions and adding to 350 existing holdings. Its largest new stake was Vanguard ESG US Stock ETF: 127,200 shares worth $7.17M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $4.65M trimmed.

  • Wedbush Securities's largest Q2 2020 buy was Vanguard ESG US Stock ETF: 127,200 shares worth $7.17M.
  • Wedbush Securities added most to First Trust Enhanced Short Maturity ETF in Q2 2020, an estimated $5.29M increase.
  • Wedbush Securities's biggest Q2 2020 reduction was Vanguard Total Stock Market ETF, cutting an estimated $4.65M.
  • Wedbush Securities fully exited Pacer Trendpilot US Large Cap ETF in Q2 2020, selling an estimated $1.36M.
  • Wedbush Securities's ten largest holdings make up 19% of its $1.06B portfolio in Q2 2020.
  • Wedbush Securities opened 162 new positions and closed 87 in Q2 2020.
  • Wedbush Securities's portfolio value rose 26% quarter-over-quarter to $1.06B.

Based on Wedbush Securities's 13F filing for Q2 2020, filed 16 Jul 2020.